FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020034088> ?p ?o ?g. }

• W2020034088 endingPage "210" @default.
• W2020034088 startingPage "207" @default.
• W2020034088 abstract "Melanoma is among the most chemotherapy-resistant malignancies. Numerous new agents have been developed that target specific molecules on cancer cells, including the monoclonal antibody trastuzumab, which targets Her2/neu and has been very beneficial in the treatment of breast cancer. There are conflicting reports in the literature about Her2/neu expression in melanoma specimens, but all of the cohorts studied have been small. We therefore examined Her2/neu expression in a very large cohort of melanoma specimens in order to determine the value of exploring trastuzumab therapy for melanoma patients. Immunohistochemical staining was performed on two tissue microarrays, together containing 600 intact specimens. Expression was evaluated semi-quantitatively and correlated with tumour stage and other clinicopathological data. Of the 600 specimens in the cohort, 31 patients (5.2%) had positive Her2/neu expression. Among the primary cutaneous specimens (n=269), 7% had positive Her2/neu staining, while 3.6% of the recurrent or metastatic specimens (n=331) had positive Her2/neu staining (P=0.06). Among the primary lesions there was no significant correlation between Her2/neu expression, Clark level and ulceration; however, Her2/neu expression was associated with lesions with a Breslow depth of <2 mm (P=0.05). Using this very large cohort of melanoma specimens, we found only a few cases with aberrant Her2/neu expression, many of them being primary cutaneous lesions rather than recurrent or metastatic lesions. Our findings suggest that drugs that specifically target Her2/neu are not likely to be useful for the treatment of metastatic melanoma or as adjuvant therapy for melanoma patients at high risk for recurrence." @default.
• W2020034088 created "2016-06-24" @default.
• W2020034088 creator A5001175430 @default.
• W2020034088 creator A5010330647 @default.
• W2020034088 creator A5027326018 @default.
• W2020034088 creator A5057160792 @default.
• W2020034088 creator A5061144291 @default.
• W2020034088 creator A5063663792 @default.
• W2020034088 creator A5085976734 @default.
• W2020034088 date "2004-06-01" @default.
• W2020034088 modified "2023-10-02" @default.
• W2020034088 title "Her2/neu is not a commonly expressed therapeutic target in melanoma – a large cohort tissue microarray study" @default.
• W2020034088 cites W1849285658 @default.
• W2020034088 cites W1992349973 @default.
• W2020034088 cites W1998456557 @default.
• W2020034088 cites W2006461916 @default.
• W2020034088 cites W2038048085 @default.
• W2020034088 cites W2054127782 @default.
• W2020034088 cites W2067667773 @default.
• W2020034088 cites W2081321744 @default.
• W2020034088 cites W2087810003 @default.
• W2020034088 cites W2313946232 @default.
• W2020034088 cites W2329269153 @default.
• W2020034088 cites W4239989216 @default.
• W2020034088 doi "https://doi.org/10.1097/01.cmr.0000130874.33504.2f" @default.
• W2020034088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15179190" @default.
• W2020034088 hasPublicationYear "2004" @default.
• W2020034088 type Work @default.
• W2020034088 sameAs 2020034088 @default.
• W2020034088 citedByCount "38" @default.
• W2020034088 countsByYear W20200340882012 @default.
• W2020034088 countsByYear W20200340882013 @default.
• W2020034088 countsByYear W20200340882014 @default.
• W2020034088 countsByYear W20200340882017 @default.
• W2020034088 countsByYear W20200340882018 @default.
• W2020034088 countsByYear W20200340882019 @default.
• W2020034088 countsByYear W20200340882020 @default.
• W2020034088 countsByYear W20200340882021 @default.
• W2020034088 countsByYear W20200340882022 @default.
• W2020034088 countsByYear W20200340882023 @default.
• W2020034088 crossrefType "journal-article" @default.
• W2020034088 hasAuthorship W2020034088A5001175430 @default.
• W2020034088 hasAuthorship W2020034088A5010330647 @default.
• W2020034088 hasAuthorship W2020034088A5027326018 @default.
• W2020034088 hasAuthorship W2020034088A5057160792 @default.
• W2020034088 hasAuthorship W2020034088A5061144291 @default.
• W2020034088 hasAuthorship W2020034088A5063663792 @default.
• W2020034088 hasAuthorship W2020034088A5085976734 @default.
• W2020034088 hasConcept C121608353 @default.
• W2020034088 hasConcept C126322002 @default.
• W2020034088 hasConcept C142724271 @default.
• W2020034088 hasConcept C143998085 @default.
• W2020034088 hasConcept C159654299 @default.
• W2020034088 hasConcept C193270364 @default.
• W2020034088 hasConcept C203014093 @default.
• W2020034088 hasConcept C204232928 @default.
• W2020034088 hasConcept C2776694085 @default.
• W2020034088 hasConcept C2776872082 @default.
• W2020034088 hasConcept C2777658100 @default.
• W2020034088 hasConcept C2779786085 @default.
• W2020034088 hasConcept C502942594 @default.
• W2020034088 hasConcept C530470458 @default.
• W2020034088 hasConcept C542903549 @default.
• W2020034088 hasConcept C71924100 @default.
• W2020034088 hasConcept C72563966 @default.
• W2020034088 hasConcept C74864618 @default.
• W2020034088 hasConceptScore W2020034088C121608353 @default.
• W2020034088 hasConceptScore W2020034088C126322002 @default.
• W2020034088 hasConceptScore W2020034088C142724271 @default.
• W2020034088 hasConceptScore W2020034088C143998085 @default.
• W2020034088 hasConceptScore W2020034088C159654299 @default.
• W2020034088 hasConceptScore W2020034088C193270364 @default.
• W2020034088 hasConceptScore W2020034088C203014093 @default.
• W2020034088 hasConceptScore W2020034088C204232928 @default.
• W2020034088 hasConceptScore W2020034088C2776694085 @default.
• W2020034088 hasConceptScore W2020034088C2776872082 @default.
• W2020034088 hasConceptScore W2020034088C2777658100 @default.
• W2020034088 hasConceptScore W2020034088C2779786085 @default.
• W2020034088 hasConceptScore W2020034088C502942594 @default.
• W2020034088 hasConceptScore W2020034088C530470458 @default.
• W2020034088 hasConceptScore W2020034088C542903549 @default.
• W2020034088 hasConceptScore W2020034088C71924100 @default.
• W2020034088 hasConceptScore W2020034088C72563966 @default.
• W2020034088 hasConceptScore W2020034088C74864618 @default.
• W2020034088 hasIssue "3" @default.
• W2020034088 hasLocation W20200340881 @default.
• W2020034088 hasLocation W20200340882 @default.
• W2020034088 hasOpenAccess W2020034088 @default.
• W2020034088 hasPrimaryLocation W20200340881 @default.
• W2020034088 hasRelatedWork W1722328147 @default.
• W2020034088 hasRelatedWork W1997026877 @default.
• W2020034088 hasRelatedWork W2057975185 @default.
• W2020034088 hasRelatedWork W2123042378 @default.
• W2020034088 hasRelatedWork W2379151083 @default.
• W2020034088 hasRelatedWork W2386812150 @default.
• W2020034088 hasRelatedWork W2934076975 @default.
• W2020034088 hasRelatedWork W3026004524 @default.
• W2020034088 hasRelatedWork W75229661 @default.

• next